Literature DB >> 29904967

Downregulation of ILT4+ dendritic cells in recurrent miscarriage and recurrent implantation failure.

Su Liu1, Hongxia Wei1, Yuye Li1, Chunyu Huang1, Ruochun Lian1, Jian Xu1, Lanna Chen1, Yong Zeng1.   

Abstract

PROBLEM: The role of ILT4+ DCs in healthy fertile controls and patients with recurrent miscarriages (RM) and recurrent implantation failure (RIF) is unclear. METHOD OF STUDY: We studied the expression of ILT4 from peripheral blood and endometrial samples from healthy controls and patients with RM and RIF by flow cytometry and immunohistochemistry analysis. Endometrial Foxp3 expression was also investigated using immunohistochemistry.
RESULTS: In peripheral blood, there was a significant increase in the percentage of ILT4+ DCs in healthy fertile controls compared with patients with RM and RIF. The presence of ILT4+ DC is even more prominent in the endometrium of healthy fertile controls compared with patients with RM and RIF. Moreover, there was a strong correlation between the number of ILT4+ cells and Foxp3+ Tregs in healthy fertile controls, but not in patients with RM and RIF.
CONCLUSION: Our data indicate that ILT4+ DCs play an important role in the maintenance of immune tolerance during pregnancy, probably through the induction of Foxp3+ Treg cells, a process which is impaired in RM and RIF.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990RIFzzm321990; zzm321990RMzzm321990; Foxp3+ Treg; ILT4+ DCs

Mesh:

Substances:

Year:  2018        PMID: 29904967     DOI: 10.1111/aji.12998

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  8 in total

1.  Bioinformatics Analysis Identifies Key Genes in Recurrent Implantation Failure Based on Immune Infiltration.

Authors:  Yuwei Duan; Yongxiang Liu; Yanwen Xu; Canquan Zhou
Journal:  Reprod Sci       Date:  2022-08-31       Impact factor: 2.924

2.  New models of lipopolysaccharide-induced implantation loss reveal insights into the inflammatory response.

Authors:  Sarah Moustafa; Dana N Joseph; Robert N Taylor; Shannon Whirledge
Journal:  Am J Reprod Immunol       Date:  2019-01-28       Impact factor: 3.886

Review 3.  The Interaction Between Microorganisms, Metabolites, and Immune System in the Female Genital Tract Microenvironment.

Authors:  Huanrong Li; Yuqin Zang; Chen Wang; Huiyang Li; Aiping Fan; Cha Han; Fengxia Xue
Journal:  Front Cell Infect Microbiol       Date:  2020-12-23       Impact factor: 5.293

Review 4.  Molecules and Prostaglandins Related to Embryo Tolerance.

Authors:  Gabriel Mayoral Andrade; Gabriela Vásquez Martínez; Laura Pérez-Campos Mayoral; María Teresa Hernández-Huerta; Edgar Zenteno; Eduardo Pérez-Campos Mayoral; Margarito Martínez Cruz; Ruth Martínez Cruz; Carlos Alberto Matias-Cervantes; Noemi Meraz Cruz; Carlos Romero Díaz; Eli Cruz-Parada; Eduardo Pérez-Campos
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

5.  Decreased Ovarian Reserves With an Increasing Number of Previous Early Miscarriages: A Retrospective Analysis.

Authors:  Jifan Tan; Lu Luo; Jiaxin Jiang; Niwei Yan; Qiong Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

Review 6.  The Role of Immune Cells in Recurrent Spontaneous Abortion.

Authors:  Dan Li; Lianwen Zheng; Donghai Zhao; Ying Xu; Yeling Wang
Journal:  Reprod Sci       Date:  2021-06-08       Impact factor: 3.060

Review 7.  Endometrial Immune Dysfunction in Recurrent Pregnancy Loss.

Authors:  Carlo Ticconi; Adalgisa Pietropolli; Nicoletta Di Simone; Emilio Piccione; Asgerally Fazleabas
Journal:  Int J Mol Sci       Date:  2019-10-26       Impact factor: 5.923

Review 8.  Metabolic Reprogramming of Immune Cells at the Maternal-Fetal Interface and the Development of Techniques for Immunometabolism.

Authors:  Yiqiu Wei; Jinli Ding; Jianan Li; Songchen Cai; Su Liu; Ling Hong; Tailang Yin; Yan Zhang; Lianghui Diao
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.